Keros Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-06-30

Reported

2025-08-06

Disclosure lag

37 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Keros Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001664710/2026-07-26
Event ID	#29261

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001664710-25-000070",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q2",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.053497942386831275,
  "metrics": {
    "cash_and_equivalents": 690215000,
    "earnings_per_share_basic": -0.76,
    "earnings_per_share_diluted": -0.76,
    "net_income": -30696000,
    "operating_income": -39817000,
    "revenue": 18168000,
    "shareholders_equity": 706734000,
    "shares_outstanding": 40615414,
    "total_assets": 757165000,
    "total_liabilities": 50431000
  },
  "metrics_reported": 10,
  "period_end": "2025-06-30"
}

Source: SEC EDGAR · as of 2025-08-06T00:00:00Z